Home
Conditions
Gram-Positive Bacterial Infections

Clinical trial condition

Gram-Positive Bacterial Infections

Explore clinical trials studying Gram-Positive Bacterial Infections. Study availability and eligibility vary by location and protocol.

2,601 public trials 262 recruiting studies

Refine in advanced search Browse all conditions

Gram-Positive Bacterial Infections trial results

Completed

Staphylococcus Aureus Bacteremia Antibiotic Treatment Options

NCT01792804

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Gram-Positive Bacterial Infections, +8 more
Locations: Annecy Annecy, France

Chambéry Chambéry, France

Grenoble Grenoble, France

La Roche-sur-Yon La Roche-sur-Yon, France

View all 40 locations

View Trial Details

Completed

Tissue Microenvironment Signatures of the Mycetoma Granuloma

NCT04401969

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +10 more
Locations: University Hospital Soba Khartoum, Sudan

View Trial Details

Completed

Livestock Contact and MRSA in Rural Areas

NCT01375621

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Gram-Positive Bacterial Infections, +3 more
Locations: University of Iowa Coralville, Iowa, United States

View Trial Details

Completed

Comparative Study of Nonintubated Uniport Thoracoscopic Surgery Using Thoracic Paravertebral Nerve Block Versus Intercostal Nerve Block for Peripheral Solitary Pulmonary Nodule Patients

NCT03086213

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +6 more
Locations: the Third People's Hospital of Shenzhen Shenzhen, Guangdong, China

View Trial Details

Completed

Study to Evaluate Efficacy of LAI When Added to Multi-drug Regimen Compared to Multi-drug Regimen Alone

NCT02344004

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +4 more
Locations: Not specified

View Trial Details

Completed

Persistence Study of GSK Biologicals' Tdap Vaccine 1, 3, 5 and 9 Years Following Administration as an Initial Single Dose in Healthy Young Adults and to Evaluate the Immunogenicity and Safety of Boostrix as a Second Dose of Tdap, When Administered at Year 9

NCT00489970

Conditions: Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +7 more
Locations: GSK Investigational Site Huntsville, Alabama, United States

GSK Investigational Site Chandler, Arizona, United States

GSK Investigational Site Mesa, Arizona, United States

GSK Investigational Site Mesa, Arizona, United States

View all 37 locations

View Trial Details

Completed

The Role of IGRA in Screening and Monitoring for TB During Anti TNF Therapy in Patients With IMID

NCT02135289

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +16 more
Locations: Prince of Wales Hospital Hong Kong

View Trial Details

Completed

Safety, Pharmacokinetics and Efficacy of KBSA301 in Severe Pneumonia (S. Aureus)

NCT01589185

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Gram-Positive Bacterial Infections, +7 more
Locations: Site 83 Jacksonville, Florida, United States

Site 81 Oklahoma City, Oklahoma, United States

Site 80 Houston, Texas, United States

Site 11 Brussels, Belgium

View all 18 locations

View Trial Details

Completed

Immunogenicity and Safety Study of NBP606 in Healthy Infants

NCT02201030

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Gram-Positive Bacterial Infections, +3 more
Locations: Confidential Seoul, South Korea

View Trial Details

Completed

Immunogenicity and Safety Study of NBP606 in Healthy Toddlers

NCT02927444

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Gram-Positive Bacterial Infections, +3 more
Locations: Clinical Research Center Seoul, South Korea

View Trial Details

Gram-Positive Bacterial Infections

Gram-Positive Bacterial Infections trial results

Related conditions